Literature DB >> 16002727

Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand.

Julian J Lum1, Gary Bren, Rebecca McClure, Andrew D Badley.   

Abstract

Neutrophils are phagocytic effectors which are produced in the bone marrow and released into the circulation. Thereafter, they are either recruited to sites of inflammation or rapidly become senescent, return to the bone marrow, and undergo apoptosis. Stromal cell-derived factor 1 (SDF-1) coordinates the return of senescent neutrophils to the bone marrow by interacting with CXCR4 that is preferentially expressed on senescent neutrophils. We demonstrate that CXCR4 ligation by SDF-1 or other CXCR4 agonists significantly increases the expression of both TNF-related apoptosis-inducing [corrected] ligand (TRAIL) and of the death-inducing TRAIL receptors on neutrophils, which confers an acquired sensitivity to TRAIL-mediated death and results in TRAIL-dependent apoptosis. In vivo administration of TRAIL antagonists results in neutrophilic accumulation within the bone marrow and a reduction in neutrophil apoptosis; conversely recombinant TRAIL administration reduced neutrophil number within bone marrow. Thus, SDF-1 ligation of CXCR4 causes the parallel processes of chemotaxis and enhanced TRAIL and TRAIL death receptor expression, resulting in apoptosis of senescent neutrophils upon their return to the bone marrow.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002727     DOI: 10.4049/jimmunol.175.2.1232

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Peculiarities of cell death mechanisms in neutrophils.

Authors:  B Geering; H-U Simon
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

Review 2.  Mitochondria in neutrophil apoptosis.

Authors:  B J van Raam; A J Verhoeven; T W Kuijpers
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 3.  Inflammation in the early stages of neurodegenerative pathology.

Authors:  Preeti J Khandelwal; Alexander M Herman; Charbel E-H Moussa
Journal:  J Neuroimmunol       Date:  2011-08-05       Impact factor: 3.478

Review 4.  Mechanisms regulating neutrophil survival and cell death.

Authors:  María Laura Gabelloni; Analía Silvina Trevani; Juan Sabatté; Jorge Geffner
Journal:  Semin Immunopathol       Date:  2013-02-01       Impact factor: 9.623

5.  Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection.

Authors:  Michelle Wilkison; Katherine Gauss; Yanchao Ran; Steve Searles; David Taylor; Nicole Meissner
Journal:  Am J Pathol       Date:  2012-05-22       Impact factor: 4.307

6.  Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults.

Authors:  Stefano Volpato; Luigi Ferrucci; Paola Secchiero; Federica Corallini; Giovanni Zuliani; Renato Fellin; Jack M Guralnik; Stefania Bandinelli; Giorgio Zauli
Journal:  Atherosclerosis       Date:  2010-11-11       Impact factor: 5.162

7.  TRAIL limits excessive host immune responses in bacterial meningitis.

Authors:  Olaf Hoffmann; Josef Priller; Timour Prozorovski; Ulf Schulze-Topphoff; Nevena Baeva; Jan D Lunemann; Orhan Aktas; Cordula Mahrhofer; Sarah Stricker; Frauke Zipp; Joerg R Weber
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

8.  CXCR4 blockade induces atherosclerosis by affecting neutrophil function.

Authors:  Ilze Bot; Isabelle T M N Daissormont; Alma Zernecke; Gijs H M van Puijvelde; Birgit Kramp; Saskia C A de Jager; Judith C Sluimer; Marco Manca; Veronica Hérias; Marijke M Westra; Martine Bot; Peter J van Santbrink; Theo J C van Berkel; Lishan Su; Mona Skjelland; Lars Gullestad; Johan Kuiper; Bente Halvorsen; Paul Aukrust; Rory R Koenen; Christian Weber; Erik A L Biessen
Journal:  J Mol Cell Cardiol       Date:  2014-05-08       Impact factor: 5.000

Review 9.  Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.

Authors:  Olaf Hoffmann; Frauke Zipp; Joerg R Weber
Journal:  J Mol Med (Berl)       Date:  2009-05-17       Impact factor: 4.599

10.  Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.

Authors:  Daniel Tesfa; Tobias Gelius; Birgitta Sander; Eva Kimby; Bengt Fadeel; Jan Palmblad; Hans Hägglund
Journal:  Med Oncol       Date:  2008-02-16       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.